— Know what they know.
Not Investment Advice
Also trades as: CELJF (OTC) · $vol 0M

CEL.TA TLV

Cellcom Israel Ltd.
1W: -2.8% 1M: +0.3% 3M: +14.6% YTD: -6.1% 1Y: +22.9% 3Y: +164.4% 5Y: +165.8%
₪3,526.00 ($11.55)
+0.00 (+0.00%)
 
TLV · Communication Services · Telecommunications Services · Tech Score Neutral · Power 47 · ₪5.9B mcap · 112M float · 0.191% daily turnover

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 2Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 01, 2026
DCF
4
ROE
5
ROA
5
D/E
2
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CEL.TA receives an overall rating of A-. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-09-22 None ADDED
2026-09-22 EXISTED None
2026-05-25 None ADDED
2026-05-25 EXISTED None
2026-04-06 None ADDED
2026-04-05 EXISTED None
2026-03-31 B+ A-
2026-03-19 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 65 Grade A
Profitability
53
Balance Sheet
56
Earnings Quality
59
Growth
54
Value
77
Momentum
82
Safety
50
Cash Flow
75
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CEL.TA scores highest in Momentum (82/100) and lowest in Safety (50/100). An overall grade of A places CEL.TA among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.16
Grey Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-2.87
Unlikely Manipulator
Ohlson O-Score
-8.00
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 63.2/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.91x
Accruals: -8.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CEL.TA scores 2.16, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CEL.TA scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CEL.TA's score of -2.87 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CEL.TA's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CEL.TA receives an estimated rating of BBB+ (score: 63.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CEL.TA's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
9.79x
PEG
0.06x
P/S
1.43x
P/B
2.11x
P/FCF
6.47x
P/OCF
4.54x
EV/EBITDA
4.95x
EV/Revenue
1.66x
EV/EBIT
15.16x
EV/FCF
8.55x
Earnings Yield
11.52%
FCF Yield
15.45%
Shareholder Yield
7.63%
Graham Number
$36.28
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 9.8x earnings, CEL.TA trades at a deep value multiple. An earnings yield of 11.5% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $36.28 per share, 9618% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.787
NI / EBT
×
Interest Burden
1.678
EBT / EBIT
×
EBIT Margin
0.110
EBIT / Rev
×
Asset Turnover
0.665
Rev / Assets
×
Equity Multiplier
2.319
Assets / Equity
=
ROE
22.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CEL.TA's ROE of 22.4% is driven by Asset Turnover (0.665), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$136.49
Price/Value
0.23x
Margin of Safety
77.46%
Premium
-77.46%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CEL.TA's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CEL.TA actually compounded EPS at 61.6% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. At an intrinsic value of $136.49, CEL.TA appears undervalued with a 77% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 9.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3526.00
Median 1Y
$3275.99
5th Pctile
$1505.28
95th Pctile
$7114.67
Ann. Volatility
46.0%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -2.0% 1.4% 2.5% 5.2% 6.5% 7.9% 8.5% 6.7% 7.1% 6.1% 4.4% 6.6% 6.5% 7.3% 9.4% 9.6% 10.1% 21.3% 22.0% 22.4% 22.39%
ROA -0.6% 0.4% 0.7% 1.5% 1.9% 2.3% 2.6% 2.1% 2.3% 2.0% 1.4% 2.2% 2.3% 2.6% 3.5% 3.6% 4.1% 8.7% 9.2% 9.7% 9.65%
ROIC 2.2% 3.1% 3.7% 4.6% 5.2% 5.5% 5.6% 4.9% 5.0% 4.9% 4.0% 5.2% 5.2% 5.9% 6.8% 6.8% 7.0% 6.7% 7.0% 7.0% 6.95%
ROCE 2.0% 4.1% 4.7% 6.1% 6.8% 7.3% 8.1% 7.1% 8.0% 7.3% 6.3% 6.2% 6.4% 7.0% 8.8% 10.2% 10.9% 9.8% 11.3% 11.1% 11.07%
Gross Margin 29.1% 28.8% 28.3% 30.2% 22.9% 35.7% 30.1% 31.5% 32.2% 28.1% 29.6% 32.5% 32.2% 32.6% 31.4% 33.6% 36.9% 35.1% 36.8% 37.2% 37.18%
Operating Margin 5.8% 6.4% 6.9% 8.9% 14.6% 4.0% 8.5% 4.7% 9.9% 7.1% 4.1% 10.1% 9.9% 9.7% 9.9% 11.2% 11.2% 4.0% 10.6% 12.4% 12.39%
Net Margin 1.3% 2.0% 2.7% 3.6% 5.7% 2.3% 4.0% 0.5% 4.7% 2.9% 0.6% 5.0% 5.0% 5.0% 5.4% 6.1% 7.4% 34.6% 7.1% 8.6% 8.64%
EBITDA Margin 28.0% 26.3% 26.9% 29.2% 43.6% 13.5% 29.0% 26.2% 29.9% 25.5% 24.2% 26.2% 31.5% 30.7% 31.4% 34.5% 35.9% 31.2% 33.8% 33.7% 33.71%
FCF Margin 13.0% 11.1% 11.2% 11.6% 12.1% 9.6% 10.1% 9.5% 9.4% 11.6% 11.4% 11.6% 12.0% 11.9% 12.6% 13.7% 15.3% 16.0% 17.5% 19.5% 19.46%
OCF Margin 26.9% 25.7% 25.6% 25.9% 29.6% 21.3% 23.4% 23.9% 21.1% 26.7% 25.6% 25.1% 25.8% 26.8% 27.5% 28.7% 28.7% 28.2% 28.5% 27.7% 27.74%
ROE 3Y Avg snapshot only 12.30%
ROE 5Y Avg snapshot only 9.69%
ROA 3Y Avg snapshot only 5.23%
ROIC 3Y Avg snapshot only 4.27%
ROIC Economic snapshot only 6.71%
Cash ROA snapshot only 18.63%
Cash ROIC snapshot only 25.69%
CROIC snapshot only 18.02%
NOPAT Margin snapshot only 7.51%
Pretax Margin snapshot only 18.42%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 9.10%
SBC / Revenue snapshot only 0.41%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -46.62 106.38 61.32 27.98 23.29 19.22 11.88 14.76 13.01 17.80 27.34 14.18 17.65 19.10 16.58 18.99 21.17 11.43 9.74 8.68 9.794
P/S Ratio 0.44 0.70 0.71 0.67 0.77 0.60 0.41 0.41 0.36 0.54 0.60 0.47 0.59 0.74 0.85 1.02 1.26 1.52 1.35 1.26 1.428
P/B Ratio 0.93 1.50 1.51 1.41 1.47 1.45 0.96 0.95 0.89 1.05 1.18 0.90 1.11 1.35 1.49 1.73 2.03 2.27 2.07 1.86 2.114
P/FCF 3.41 6.33 6.36 5.83 6.34 6.31 4.04 4.29 3.83 4.68 5.25 4.04 4.97 6.23 6.74 7.47 8.25 9.52 7.71 6.47 6.472
P/OCF 1.65 2.73 2.79 2.60 2.59 2.84 1.74 1.70 1.71 2.03 2.35 1.86 2.31 2.76 3.08 3.56 4.39 5.39 4.75 4.54 4.539
EV/EBITDA 4.51 5.13 5.19 4.86 4.98 4.87 4.01 4.06 3.72 4.01 4.39 3.84 4.25 4.47 4.52 4.72 5.25 5.80 5.15 4.95 4.947
EV/Revenue 1.13 1.38 1.39 1.34 1.52 1.17 0.98 0.96 0.83 1.11 1.16 1.02 1.14 1.26 1.35 1.51 1.74 1.92 1.74 1.66 1.664
EV/EBIT 47.75 28.37 25.91 18.96 17.44 15.88 12.37 14.00 12.46 14.47 18.49 16.29 18.50 18.16 16.05 14.85 15.97 18.23 15.91 15.16 15.156
EV/FCF 8.72 12.44 12.37 11.57 12.51 12.18 9.68 10.18 8.86 9.56 10.15 8.79 9.53 10.55 10.77 11.04 11.38 12.06 9.93 8.55 8.551
Earnings Yield -2.1% 0.9% 1.6% 3.6% 4.3% 5.2% 8.4% 6.8% 7.7% 5.6% 3.7% 7.1% 5.7% 5.2% 6.0% 5.3% 4.7% 8.8% 10.3% 11.5% 11.52%
FCF Yield 29.4% 15.8% 15.7% 17.2% 15.8% 15.8% 24.8% 23.3% 26.1% 21.4% 19.0% 24.7% 20.1% 16.0% 14.8% 13.4% 12.1% 10.5% 13.0% 15.5% 15.45%
PEG Ratio snapshot only 0.062
Price/Tangible Book snapshot only 6.953
EV/OCF snapshot only 5.997
EV/Gross Profit snapshot only 4.560
Acquirers Multiple snapshot only 17.447
Shareholder Yield snapshot only 7.63%
Graham Number snapshot only $36.28
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.05 1.05 0.95 0.97 1.05 1.05 0.96 0.97 0.81 0.83 0.75 0.77 0.65 0.75 0.67 0.70 0.62 0.78 0.61 0.65 0.647
Quick Ratio 1.00 1.00 0.90 0.90 0.99 0.98 0.89 0.91 0.76 0.77 0.68 0.71 0.60 0.68 0.60 0.65 0.57 0.73 0.56 0.59 0.585
Debt/Equity 1.78 1.78 1.75 1.75 1.77 1.72 1.59 1.57 1.35 1.32 1.31 1.30 1.10 1.08 0.97 0.95 0.83 0.78 0.71 0.69 0.687
Net Debt/Equity 1.45 1.44 1.42 1.39 1.43 1.35 1.34 1.31 1.17 1.10 1.10 1.05 1.02 0.93 0.89 0.82 0.77 0.61 0.59 0.60 0.599
Debt/Assets 0.53 0.52 0.52 0.52 0.52 0.52 0.50 0.50 0.46 0.45 0.45 0.45 0.42 0.41 0.39 0.39 0.36 0.34 0.31 0.31 0.311
Debt/EBITDA 3.36 3.11 3.10 3.03 3.04 2.99 2.76 2.83 2.44 2.46 2.53 2.55 2.20 2.12 1.85 1.75 1.56 1.57 1.37 1.38 1.379
Net Debt/EBITDA 2.75 2.52 2.52 2.41 2.46 2.35 2.34 2.35 2.11 2.05 2.12 2.07 2.03 1.83 1.69 1.52 1.44 1.22 1.15 1.20 1.203
Interest Coverage 0.65 1.23 1.39 1.80 2.02 2.69 2.71 2.50 2.68 2.29 2.11 2.20 2.24 2.15 2.74 3.34 3.53 3.47 3.72 4.27 4.271
Equity Multiplier 3.36 3.42 3.39 3.38 3.38 3.33 3.19 3.18 2.93 2.93 2.94 2.86 2.65 2.65 2.51 2.44 2.31 2.29 2.28 2.20 2.205
Cash Ratio snapshot only 0.119
Debt Service Coverage snapshot only 13.084
Cash to Debt snapshot only 0.128
FCF to Debt snapshot only 0.419
Defensive Interval snapshot only 405.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.61 0.60 0.60 0.61 0.59 0.75 0.75 0.75 0.82 0.65 0.66 0.66 0.70 0.68 0.68 0.67 0.69 0.65 0.66 0.67 0.665
Inventory Turnover 35.32 36.81 26.82 23.85 28.62 33.94 28.52 25.30 35.84 26.48 21.00 24.94 31.74 23.05 20.27 27.34 27.92 21.99 22.63 23.30 23.295
Receivables Turnover 4.33 4.29 4.35 4.63 4.41 5.63 5.79 5.89 6.14 4.93 4.98 5.25 5.10 5.29 4.98 5.21 5.01 5.28 4.86 4.73 4.725
Payables Turnover 4.59 8.25 3.71 4.11 4.07 8.11 4.49 4.62 4.78 6.37 3.75 4.19 4.00 6.31 3.68 4.23 3.90 4.69 3.66 3.85 3.846
DSO 84 85 84 79 83 65 63 62 59 74 73 70 72 69 73 70 73 69 75 77 77.2 days
DIO 10 10 14 15 13 11 13 14 10 14 17 15 11 16 18 13 13 17 16 16 15.7 days
DPO 80 44 98 89 90 45 81 79 76 57 97 87 91 58 99 86 94 78 100 95 94.9 days
Cash Conversion Cycle 15 51 -1 5 6 31 -5 -3 -7 30 -7 -3 -8 27 -8 -3 -8 8 -8 -2 -2.0 days
Fixed Asset Turnover snapshot only 1.994
Operating Cycle snapshot only 92.9 days
Cash Velocity snapshot only 16.854
Capital Intensity snapshot only 1.489
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 10.4% 11.5% 8.0% 5.6% -2.2% 23.3% 23.3% 21.4% 40.2% -13.0% -12.2% -11.7% -18.3% 1.3% -0.8% -2.7% -4.3% -4.7% -6.3% -4.7% -4.74%
Net Income 79.0% 1.2% 1.4% 2.1% 4.4% 4.9% 2.6% 38.6% 17.8% -15.7% -43.7% 5.7% -0.7% 29.1% 1.3% 58.8% 68.9% 2.3% 1.5% 1.6% 1.57%
EPS 78.3% 1.2% 1.4% 2.1% 4.2% 4.8% 2.6% 41.0% 21.5% -13.4% -46.8% 5.7% -0.1% 29.7% 1.4% 57.1% 64.7% 2.1% 1.5% 1.5% 1.54%
FCF 21.5% -8.1% -1.1% -3.6% -8.8% 6.6% 10.6% -0.8% 8.9% 5.4% -0.4% 7.9% 3.9% 3.9% 9.0% 15.0% 22.0% 27.7% 30.8% 35.7% 35.68%
EBITDA 13.3% 23.9% 19.2% 20.2% 18.3% 9.9% 12.1% 4.4% 3.1% 0.5% -4.8% -1.6% -2.1% 3.0% 12.3% 17.7% 17.9% 12.5% 5.9% 0.2% 0.21%
Op. Income 4.9% 10.1% 24.8% 3.6% 1.7% 73.2% 64.2% 14.3% 0.3% -8.0% -24.4% 3.9% 1.8% 12.3% 51.7% 26.9% 29.0% 2.9% -12.6% -10.4% -10.38%
OCF Growth snapshot only -7.82%
Asset Growth snapshot only -1.82%
Equity Growth snapshot only 8.82%
Debt Growth snapshot only -21.05%
Shares Change snapshot only 1.16%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 2.2% 3.6% 3.8% 4.4% 1.9% 10.9% 11.4% 12.1% 14.8% 6.2% 5.3% 4.2% 3.8% 2.8% 2.4% 1.4% 3.1% -5.7% -6.6% -6.4% -6.44%
Revenue 5Y -0.4% 0.4% 0.8% 1.5% 0.2% 5.5% 5.7% 5.9% 7.9% 3.6% 3.9% 4.1% 3.9% 3.7% 3.8% 3.9% 3.4% 2.9% 1.7% 1.0% 0.98%
EPS 3Y — — — — — — — — — — — — — 87.2% 65.4% 32.8% 26.0% 52.2% 47.3% 61.6% 61.60%
EPS 5Y — -35.8% -23.8% -12.3% -7.9% -3.4% 2.5% 48.1% — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — 85.7% 67.6% 32.5% 25.5% 52.5% 49.0% 62.8% 62.79%
Net Income 5Y — -28.8% -16.0% -2.7% 2.3% 7.3% 13.1% 63.5% — — — — — — — — — — — — —
EBITDA 3Y 11.5% 17.0% 14.1% 12.1% 10.2% 8.9% 9.8% 9.5% 11.4% 11.0% 8.4% 7.3% 6.1% 4.4% 6.2% 6.5% 6.0% 5.2% 4.2% 5.1% 5.10%
EBITDA 5Y 2.8% 5.3% 6.3% 7.8% 7.9% 7.6% 8.5% 9.6% 11.1% 12.1% 9.7% 7.7% 6.2% 6.0% 7.2% 8.7% 9.8% 9.7% 8.6% 7.8% 7.82%
Gross Profit 3Y -0.8% 3.4% 5.7% 7.5% 3.5% 17.1% 17.1% 19.5% 26.8% 15.2% 14.9% 12.0% 9.1% 7.5% 6.7% 5.1% 9.5% -2.7% -2.7% -2.1% -2.06%
Gross Profit 5Y -5.5% -3.0% -1.5% 0.3% -1.5% 5.8% 6.6% 7.6% 10.9% 5.4% 6.4% 7.0% 6.8% 7.5% 7.4% 8.4% 10.1% 10.6% 10.6% 9.2% 9.23%
Op. Income 3Y 4.9% 41.4% 82.8% 73.8% 83.7% 1.5% 1.3% 3.1% — — 2.2% 76.0% 39.6% 21.4% 23.5% 14.6% 9.6% 2.1% 0.1% 5.7% 5.72%
Op. Income 5Y -18.5% -7.6% -3.4% 1.4% 3.7% 4.0% 6.7% 15.9% 25.2% 35.1% 49.9% 44.2% 44.6% 73.2% 67.6% 1.5% — — 1.1% 44.1% 44.05%
FCF 3Y 29.0% 36.9% 29.7% 21.6% 9.6% 0.3% 2.0% 1.6% 6.4% 1.1% 2.9% 1.0% 1.0% 5.3% 6.3% 7.2% 11.3% 11.8% 12.4% 19.0% 18.97%
FCF 5Y 2.8% 1.9% 18.2% 21.1% 19.2% 20.4% 8.7% 10.0% 16.4% 23.6% 19.2% 14.0% 8.3% 2.0% 2.9% 5.4% 8.8% 6.5% 9.2% 10.0% 10.00%
OCF 3Y 9.6% 11.0% 7.8% 7.1% 6.4% 1.3% 6.9% 8.5% 9.6% 5.7% 6.2% 4.1% 2.4% 4.3% 4.9% 4.9% 2.0% 3.6% -0.3% -1.7% -1.67%
OCF 5Y 5.7% 6.1% 11.3% 9.4% 9.4% 6.8% 5.1% 8.0% 7.2% 8.8% 6.2% 5.0% 3.7% 2.9% 4.6% 5.7% 7.0% 3.8% 4.4% 2.9% 2.88%
Assets 3Y 0.7% -0.9% -3.5% -1.6% 0.3% -0.8% 0.5% 0.4% -1.2% -2.6% -2.1% -1.2% -0.3% -0.3% -1.5% -2.3% -3.8% -2.4% -3.3% -3.4% -3.37%
Assets 5Y -0.1% -0.3% 1.6% 1.2% 3.0% 2.8% 2.3% 1.5% 0.8% -0.4% -1.9% -1.2% -1.6% -1.9% -1.3% -1.4% -1.8% -1.9% -2.7% -2.2% -2.17%
Equity 3Y 4.8% 4.7% 5.6% 7.1% 8.0% 3.7% 4.9% 4.9% 5.0% 6.4% 6.3% 7.4% 8.0% 8.5% 8.8% 8.9% 9.2% 10.5% 8.0% 9.1% 9.12%
Book Value 3Y -7.1% -7.7% -6.0% -5.5% -5.1% -1.1% 1.2% 2.0% 5.6% 8.2% 6.3% 5.0% 7.5% 9.4% 7.4% 9.2% 9.6% 10.2% 6.7% 8.3% 8.33%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.13 0.00 0.05 0.22 0.07 0.46 0.53 0.61 0.51 0.56 0.61 0.65 0.44 0.40 0.40 0.39 0.23 0.10 0.02 0.00 0.002
Earnings Stability 0.67 0.41 0.24 0.05 0.00 0.03 0.12 0.34 0.47 0.63 0.70 0.80 0.78 0.80 0.85 0.91 0.87 0.82 0.81 0.81 0.814
Margin Stability 0.87 0.88 0.89 0.91 0.92 0.89 0.89 0.90 0.89 0.90 0.89 0.90 0.90 0.92 0.93 0.92 0.87 0.87 0.85 0.86 0.863
Rev. Growth Consistency 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.94 0.83 0.98 1.00 0.88 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — — — 0.00 0.00 0.68 0.84 0.83 0.44 0.94 0.99 0.75 0.21 0.55 0.49 0.00 0.13 0.12 0.120
ROE Trend 0.05 0.09 0.09 0.11 0.12 0.11 0.10 0.06 0.05 0.01 -0.01 0.01 -0.00 0.00 0.03 0.03 0.03 0.13 0.15 0.14 0.138
Gross Margin Trend 0.01 0.03 0.03 0.04 0.03 0.05 0.06 0.05 0.06 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.03 0.04 0.05 0.050
FCF Margin Trend 0.02 -0.02 -0.01 -0.01 -0.00 -0.03 -0.02 -0.03 -0.03 0.01 0.01 0.01 0.01 0.01 0.02 0.03 0.05 0.04 0.06 0.07 0.068
Sustainable Growth Rate — 1.4% 2.5% 5.2% 6.5% 7.9% 8.5% 6.7% 7.1% 6.1% 4.4% 6.6% 6.5% 7.3% 9.4% 9.6% 10.1% 13.8% 14.4% 7.6% 7.56%
Internal Growth Rate — 0.4% 0.7% 1.5% 2.0% 2.4% 2.6% 2.1% 2.3% 2.0% 1.5% 2.2% 2.4% 2.7% 3.6% 3.8% 4.2% 5.9% 6.4% 3.4% 3.37%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -28.32 38.96 22.00 10.74 8.98 6.77 6.84 8.68 7.61 8.75 11.63 7.63 7.65 6.91 5.39 5.33 4.82 2.12 2.05 1.91 1.912
FCF/OCF 0.48 0.43 0.44 0.45 0.41 0.45 0.43 0.40 0.45 0.43 0.45 0.46 0.46 0.44 0.46 0.48 0.53 0.57 0.62 0.70 0.701
FCF/Net Income snapshot only 1.341
OCF/EBITDA snapshot only 0.825
CapEx/Revenue 13.9% 14.6% 14.4% 14.3% 17.5% 11.7% 13.3% 14.4% 11.7% 15.1% 14.1% 13.6% 13.8% 14.9% 15.0% 15.0% 13.4% 12.2% 11.0% 8.3% 8.29%
CapEx/Depreciation snapshot only 0.366
Accruals Ratio -0.17 -0.15 -0.15 -0.14 -0.15 -0.14 -0.15 -0.16 -0.15 -0.15 -0.15 -0.14 -0.16 -0.16 -0.15 -0.16 -0.16 -0.10 -0.10 -0.09 -0.088
Sloan Accruals snapshot only -0.172
Cash Flow Adequacy snapshot only 1.550
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.1% 3.6% 7.6% 6.75%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.16 $1.17 $2.35 $2.38
Payout Ratio — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 35.5% 34.7% 66.2% 66.23%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 29.5% 27.5% 49.4% 49.38%
Total Payout Ratio — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 35.5% 34.7% 66.2% 66.23%
Div. Increase Streak — — — — — — — — — — — — — — — — — 0 0 0 0
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -3.0% -2.6% -2.2% -1.8% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -3.0% -2.6% -2.2% -1.8% 3.1% 3.6% 7.6% 7.63%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.78 0.69 0.75 0.75 0.76 0.75 0.75 0.74 0.72 0.71 0.67 0.71 0.72 0.74 0.74 0.73 0.73 0.79 0.79 0.79 0.787
Interest Burden (EBT/EBIT) -0.52 0.20 0.29 0.45 0.50 0.57 0.58 0.54 0.57 0.56 0.53 0.75 0.76 0.76 0.82 0.73 0.75 1.59 1.60 1.68 1.678
EBIT Margin 0.02 0.05 0.05 0.07 0.09 0.07 0.08 0.07 0.07 0.08 0.06 0.06 0.06 0.07 0.08 0.10 0.11 0.11 0.11 0.11 0.110
Asset Turnover 0.61 0.60 0.60 0.61 0.59 0.75 0.75 0.75 0.82 0.65 0.66 0.66 0.70 0.68 0.68 0.67 0.69 0.65 0.66 0.67 0.665
Equity Multiplier 3.44 3.61 3.57 3.52 3.37 3.37 3.28 3.28 3.15 3.12 3.06 3.01 2.78 2.78 2.71 2.64 2.47 2.46 2.39 2.32 2.319
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.23 $0.16 $0.29 $0.60 $0.76 $0.93 $1.05 $0.84 $0.92 $0.81 $0.56 $0.89 $0.92 $1.05 $1.32 $1.40 $1.51 $3.28 $3.36 $3.55 $3.55
Book Value/Share $11.71 $11.33 $11.86 $11.79 $11.99 $12.32 $13.02 $12.98 $13.42 $13.61 $13.01 $14.01 $14.54 $14.82 $14.68 $15.34 $15.78 $16.50 $15.83 $16.51 $16.68
Tangible Book/Share $-1.45 $-1.23 $-1.13 $-0.84 $-0.58 $-0.29 $0.01 $0.10 $0.46 $0.71 $0.79 $1.24 $1.67 $2.08 $2.42 $2.89 $3.42 $4.37 $3.74 $4.43 $4.43
Revenue/Share $24.63 $24.18 $25.03 $24.70 $22.91 $29.60 $30.73 $30.50 $33.14 $26.45 $25.49 $26.94 $27.21 $26.91 $25.80 $25.95 $25.38 $24.70 $24.18 $24.44 $24.70
FCF/Share $3.20 $2.68 $2.81 $2.86 $2.77 $2.83 $3.10 $2.89 $3.12 $3.07 $2.91 $3.11 $3.25 $3.20 $3.24 $3.54 $3.87 $3.94 $4.24 $4.75 $4.80
OCF/Share $6.62 $6.20 $6.41 $6.40 $6.78 $6.30 $7.20 $7.29 $6.99 $7.05 $6.51 $6.77 $7.01 $7.22 $7.11 $7.44 $7.28 $6.96 $6.89 $6.78 $6.85
Cash/Share $3.82 $3.80 $3.89 $4.17 $4.07 $4.52 $3.22 $3.44 $2.42 $2.99 $2.75 $3.41 $1.22 $2.24 $1.23 $1.88 $0.95 $2.83 $1.81 $1.45 $1.47
EBITDA/Share $6.20 $6.49 $6.70 $6.81 $6.97 $7.08 $7.49 $7.24 $7.41 $7.31 $6.74 $7.12 $7.30 $7.57 $7.72 $8.29 $8.39 $8.20 $8.18 $8.22 $8.22
Debt/Share $20.83 $20.16 $20.78 $20.61 $21.19 $21.13 $20.70 $20.44 $18.09 $17.98 $17.02 $18.18 $16.03 $16.07 $14.29 $14.52 $13.06 $12.86 $11.23 $11.33 $11.33
Net Debt/Share $17.02 $16.36 $16.90 $16.44 $17.12 $16.61 $17.48 $17.00 $15.67 $14.99 $14.27 $14.77 $14.81 $13.83 $13.06 $12.65 $12.11 $10.02 $9.42 $9.88 $9.88
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.157
Altman Z-Prime snapshot only 2.409
Piotroski F-Score 7 8 8 7 5 7 8 9 8 5 4 7 6 8 8 6 6 7 7 6 6
Beneish M-Score -3.50 -2.83 -3.40 -3.32 -2.97 -2.54 -3.20 -3.23 -3.19 0.04 -3.17 -3.21 -3.22 -3.30 -3.24 -3.21 -3.26 -3.00 -3.04 -2.87 -2.874
Ohlson O-Score snapshot only -8.000
ROIC (Greenblatt) snapshot only 33.65%
Net-Net WC snapshot only $-12.02
EVA snapshot only $-136968970.01
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB+
Credit Score 26.71 34.68 32.17 35.38 40.90 42.58 40.94 41.46 40.74 40.68 39.06 39.18 40.98 40.62 44.81 54.66 55.39 63.90 64.84 63.19 63.186
Credit Grade snapshot only 8
Credit Trend snapshot only 8.523
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 64
Sector Credit Rank snapshot only 57

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms